Atlas Trials

Tubulis GmbH

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tubulis GmbH

RecordFirmDate
Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy (NCT07743541)Tubulis GmbH2026-10-01
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer (NCT07736937)Tubulis GmbH2026-03-30
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors (NCT06657222)Tubulis GmbH2024-12-13
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC (NCT06303505)Tubulis GmbH2024-06-12

Track Tubulis GmbH automatically

Every clearance here is in the API, with alerts when new ones post.